KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Amortizatization of Intangibles: 2018-2024

Historic Amortizatization of Intangibles for Castle Biosciences (CSTL) over the last 5 years, with Dec 2024 value amounting to $6.7 million.

  • Castle Biosciences' Amortizatization of Intangibles fell 45.15% to $905,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 23.66%. This contributed to the annual value of $6.7 million for FY2024, which is 21.74% up from last year.
  • Per Castle Biosciences' latest filing, its Amortizatization of Intangibles stood at $6.7 million for FY2024, which was up 21.74% from $5.5 million recorded in FY2023.
  • In the past 5 years, Castle Biosciences' Amortizatization of Intangibles ranged from a high of $6.7 million in FY2024 and a low of $1.4 million during FY2022.
  • For the 3-year period, Castle Biosciences' Amortizatization of Intangibles averaged around $4.5 million, with its median value being $5.5 million (2023).
  • Data for Castle Biosciences' Amortizatization of Intangibles shows a peak YoY skyrocketed of 301.39% (in 2023) over the last 5 years.
  • Castle Biosciences' Amortizatization of Intangibles (Yearly) stood at $1.4 million in 2022, then surged by 301.39% to $5.5 million in 2023, then grew by 21.74% to $6.7 million in 2024.